Vaxil Bio Enters Into Letter of Intent With Green Data in Respect of A Proposed Reverse Takeover
27 mai 2024 06h30 HE
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Bio Proposed Reverse Takeover with Copper Bullet Terminated and Update of Research Activities
04 mars 2024 09h57 HE
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Bio Enters Into Letter of Intent With Copper Bullet Mines in Respect of a Proposed Reverse Takeover
10 janv. 2024 15h01 HE
|
Vaxil Bio Ltd.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States ...
Vaxil Provides Update on Research Activities and Management Changes
02 août 2023 17h00 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. ("Vaxil" or the "Company") (TSX VENTURE:VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil’s Annual and Special Shareholders Meeting
24 avr. 2023 19h50 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Update on Research Activities
07 mars 2022 07h50 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil’s Annual and Special Shareholders Meeting
08 févr. 2022 17h30 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Final Results on Its Previously Disclosed Research With Ben-Gurion University of the Negev
04 janv. 2022 10h02 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 04, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Resignation of Director
13 déc. 2021 16h30 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Dec. 13, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that Mr. David Goren has resigned from the...
Vaxil Announces Change of Auditor
12 nov. 2021 17h10 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel , Nov. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...